# Anthrasil

NDC: 60492-0249
Generic name: Anthrax immune globulin (human)
Labeler / Manufacturer: Emergent BioSolutions Canada Inc.
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: LIQUID
Routes: INTRAVENOUS
Marketing started: 20151005

FDA application: BLA125562

## Active ingredients

- ANTHRAX IMMUNE GLOBULIN HUMAN: 60 [iU]/35mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60492-0249"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60492-0249

